+++What does PPHM still need money wise to get the job done solo? Maybe another $50 to $100 million on top of the $30 million, plus curtailed spending on nonessential operations?
What is Cotara worth if it is sold outright after the FDA replies with a P3 decision? Any estimates? I understand that the paved path would be partnering, but wouldn’t the proceeds of a Cotara sale coupled with the recent loan provide enough capital to at least give the impression that Peregrine could go it alone?